NKTR · Nektar Therapeutics · Investor Relations
$35.91
-0.53 (-1.45%)
At close · Nov 17
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.23B
Shares
34.21M
Volume · Nov 17
731.15K
Avg daily vol (3M)
1.1M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-18 | Jefferies Global Healthcare Conference | Conference |
| 2026-11-18 | Jefferies Global Healthcare Conference in London | Conference |
| 2026-11-17 | UBS Global Biopharma Conference | Conference |
| 2026-11-12 | Nektar Therapeutics Q3 2026 Financial Results | Earnings call |
| 2026-10-01 | Analyst and Investor Event at EADV | Event |
| 2026-08-13 | Nektar Therapeutics Q2 2026 Financial Results | Earnings call |
| 2026-06-03 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-05-07 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-07 | Nektar Therapeutics Q1 2026 Financial Results | Earnings call |
| 2026-04-20 | Analyst and Investor Event with Alopecia Areata Experts | Event |
| 2026-03-12 | Q4 Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.nektar.com/
Key facts
CIK
906709
CUSIP
640268306
13F (30d)
280 filings
243 filers
Visit website
Investor relations